Citation Impact
Citing Papers
Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons
2008 StandoutScience
A Pan-cancer Analysis of the Expression and Clinical Relevance of Small Nucleolar RNAs in Human Cancer
2017
Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis
2016
Affinity Capture and Identification of Host Cell Factors Associated with Hepatitis C Virus (+) Strand Subgenomic RNA
2013
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
2017 Standout
Therapeutic Immunity by Adoptive Tumor-primed CD4+ T-cell Transfer in Combination With In Vivo GITR Ligation
2009 StandoutNobel
Structure of the PAPP-ABP5 complex reveals mechanism of substrate recognition
2022 StandoutNobel
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Hepatocellular carcinoma
2003 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Dendritic cells engineered to secrete anti-GITR antibodies are effective adjuvants to dendritic cell-based immunotherapy
2009
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: An indication for salvage liver transplantation
2004
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
1999 Standout
Improved Diagnostic Imaging and Interventional Therapies Prolong Survival After Resection for Hepatocellular Carcinoma in Cirrhosis: The University of Bologna Experience Over 10 Years
2010
Hepatocellular carcinoma
2018 Standout
A Model to Predict Survival in Patients With End–Stage Liver Disease
2001 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Integrins in cancer: biological implications and therapeutic opportunities
2009 Standout
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis
1990
Mutations in the glutamate transporter EAAT2 gene do not cause abnormal EAAT2 transcripts in amyotrophic lateral sclerosis
1998 StandoutNobel
Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines
1996
Effect of Testosterone Administration on Sexual Behavior and Mood in Men with Erectile Dysfunction
1997
Erectile Dysfunction
2000 Standout
Wnt5A Activates the Calpain-Mediated Cleavage of Filamin A
2009
The emerging role of lncRNAs in cancer
2015 Standout
Knockout of Glutamate Transporters Reveals a Major Role for Astroglial Transport in Excitotoxicity and Clearance of Glutamate
1996 Standout
From charcot to lou gehrig: deciphering selective motor neuron death in als
2001
Prospects for cationic polymers in gene and oligonucleotide therapy against cancer
2002
Pancreatic cancer
2016 Standout
Hepatocellular carcinoma
2012 Standout
Amyotrophic lateral sclerosis
2011 Standout
New horizons in adjuvants for vaccine development
2020
Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma†
2008
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Management of Hepatocellular Carcinoma *
2005 Standout
Protein aggregation and neurodegenerative disease
2004 Standout
Combinations of Bevacizumab With Cancer Immunotherapy
2018
Branched-chain amino acids in the treatment of amyotrophic lateral sclerosis
1989
Effectiveness of clinical breast examination as a ‘stand-alone’ screening modality: an overview of systematic reviews
2020
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
2015
Management of HCC
2012
Biliary Tract Cancers
1999
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
1996 Standout
Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
1997
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
2015
Neuroblastoma
2007 Standout
PAPP-A and the IGF system
2016
ALS-Linked SOD1 Mutant G85R Mediates Damage to Astrocytes and Promotes Rapidly Progressive Disease with SOD1-Containing Inclusions
1997 Standout
Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
2011
TRIM28 prevents autoinflammatory T cell development in vivo
2012 StandoutNobel
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
2021
Production and Actions of Estrogens
2002 Standout
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
1994 Standout
Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosis
1997 StandoutNobel
Intracellular demonstration of active TGFbeta1 in B cells and plasma cells of autoimmune mice. IgG-bound TGFbeta1 suppresses neutrophil function and host defense against Staphylococcus aureus infection.
1996
Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
1992
Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation
2015
Excitotoxicity and motor neurone disease: A review of the evidence
1994
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
1994 Standout
Hepatocellular Carcinoma
2011 Standout
VEGF in Signaling and Disease: Beyond Discovery and Development
2019 Standout
Tumor markers in patients with pancreatic carcinoma
1996
Amyotrophic Lateral Sclerosis
2001 Standout
Pleural mesothelioma
1999
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
2017
Advances in Malignant Mesothelioma
2005 Standout
Up-regulation of Akt3 in Estrogen Receptor-deficient Breast Cancers and Androgen-independent Prostate Cancer Lines
1999 Standout
Hepatocellular carcinoma
2022 Standout
Targeted Therapies for Hepatocellular Carcinoma
2011
Hepatocellular carcinoma: clinical frontiers and perspectives
2014
Hepatocellular Carcinoma
2019 Standout
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
Plasma Biomarkers as Predictors of Outcome in Patients with Advanced Hepatocellular Carcinoma
2012
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
2011 StandoutNobel
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Vesicles and Liposomes: A Self‐Assembly Principle Beyond Lipids
2003 Standout
Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and Therapy
2010
A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
2022 StandoutNobel
Impact of Natural Products on Developing New Anti-Cancer Agents
2009 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Aplidine: A Paradigm of how to Handle the Activity and Toxicity of a Novel Marine Anticancer Poison
2007
Oxidative Stress, Glutamate, and Neurodegenerative Disorders
1993 StandoutScience
Androgen Receptor Overexpression in Prostate Cancer Linked to Purα Loss from a Novel Repressor Complex
2008
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Therapeutic cancer vaccines
2015
Neoadjuvant and adjuvant therapy for surgical resection of hepatocellular carcinoma
2009
Systematic review and meta-analysis of interferon after curative treatment of hepatocellular carcinoma in patients with viral hepatitis
2009
Biological Esterification of Steroids*
1998
Works of John Mandeli being referenced
Therapeutic Immune Modulation against Solid Cancers with Intratumoral Poly-ICLC: A Pilot Trial
2018
Lactation opposes pappalysin‐1‐driven pregnancy‐associated breast cancer
2016
Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study
2004
Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the randomised clinical trials
2002
Combined Modality Therapy Increasing Local Control of Pancreatic Cancer
1993
Serum of patients with prostatic cancer or benign prostatic hypertrophy contains nonpolar testosterone
1990
Gene-expression signature of vascular invasion in hepatocellular carcinoma
2011
Intratumoral Adenovirus-Mediated Suicide Gene Transfer for Hepatic Metastases from Colorectal Adenocarcinoma: Results of a Phase I Clinical Trial
2001
Increase of Plasma Transforming Growth Factor Beta (TGFβ) During Immunotherapy with IL-2
1995
Hormones and nocturnal penile tumescence in healthy aging men
1993
All-trans retinoic acid and interferon-?-2a in patients with metastatic or recurrent carcinoma of the uterine cervix
1997
Survival After Combined Modality Therapy for Pancreatic Cancer
1993
Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice
1998
Circulating Pancreatic Polypeptide in Patients with Adenocarcinoma of the Bile Duct
1993
Rejection of Metastatic 4T1 Breast Cancer by Attenuation of Treg Cells in Combination With Immune Stimulation
2007
PILOT TRIAL OF BRANCHED-CHAIN AMINOACIDS IN AMYOTROPHIC LATERAL SCLEROSIS
1988
Expression of Wnt5A and Wnt10B in non-immortalized breast cancer cells
2007
Molecular Load of Pathologically Occult Metastases in Pelvic Lymph Nodes Is an Independent Prognostic Marker of Biochemical Failure After Localized Prostate Cancer Treatment
2006
The effect of dihydrotestosterone and culture conditions on proliferation of the human prostatic cancer cell line LNCaP
1992
Phase II Trial Evaluating the Clinical and Biologic Effects of Bevacizumab in Unresectable Hepatocellular Carcinoma
2008
Downstaging cancer in rural Africa
2014